Skip to main content
Premium Trial:

Request an Annual Quote

Biofortuna Closes $2.2M Funding Round

NEW YORK(GenomeWeb) – Molecular diagnostics firm Biofortuna has raised £1.5 million ($2.2 million) in its latest private funding round, the company announced today.

Based in the UK, Biofortuna offers contract in vitro diagnostics development, lyophilization, and stabilization services in its FDA- and ISO13485-approved facilities.

The company also manufactures its own molecular diagnostic products for the transplantation, disease identification, and pharmacogenetic markets. Its SSPgo kits for HLA typing are distributed by Abbott and received 510(k) clearance from the US Food and Drug Administration last year.

The new funding will support development of a portfolio of molecular diagnostic assays that address complex genotyping issues, the company said in a statement. It will also support further investment in Biofortuna's freeze-drying production capability to meet projected growth.

The company recently expanded its PCR reagent lyophilization production service citing increased demand, as reported by GenomeWeb, and received investment of £1.3 million ($2.0 million) for expansion of its custom service and manufacturing business.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.